Skip Navigation


International Immunology Advance Access originally published online on February 27, 2007
International Immunology 2007 19(4):345-354; doi:10.1093/intimm/dxm014
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
19/4/345    most recent
dxm014v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (58)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Allan, S. E.
Right arrow Articles by Levings, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Allan, S. E.
Right arrow Articles by Levings, M. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Japanese Society for Immunology. 2007. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production

Sarah E. Allan1, Sarah Q. Crome1, Natasha K. Crellin1, Laura Passerini2, Theodore S. Steiner3, Rosa Bacchetta2, Maria G. Roncarolo2,4 and Megan K. Levings1

1 Department of Surgery, University of British Columbia, and Immunity and Infection Research Centre, Vancouver Coastal Health Research Institute, 2660 Oak Street, Vancouver, Canada
2 San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), Via Olgettina 58, Milan, Italy
3 Department of Medicine, University of British Columbia and Immunity and Infection Research Centre, Vancouver Coastal Health Research Institute, Vancouver, Canada
4 Vita-Salute San Raffaele University, Via Olgettina 58, Milan, Italy

Correspondence to: M. K. Levings; E-mail: mlevings{at}interchange.ubc.ca

Forkhead box P3 (FOXP3) is currently thought to be the most specific marker for naturally occurring CD4+CD25+ T regulatory cells (nTregs). In mice, expression of FoxP3 is strictly correlated with regulatory activity, whereas increasing evidence suggests that in humans, activated T effector cells (Teffs) may also express FOXP3. In order to better define the role of FOXP3 in human Teff cells, we investigated the intensity and kinetics of expression in ex vivo Teff cells, suppressed Teff cells and Teff cell lines. We found that all dividing Teff cells expressed FOXP3, but only transiently, and at levels that were significantly lower than those in suppressive nTregs. This temporary expression in Teff cells was insufficient to suppress expression of reported targets of FOXP3 repressor activity, including CD127, IL-2 and IFN-{gamma}, and was not correlated with induction of a nTreg phenotype. Thus expression of FOXP3 is a normal consequence of CD4+ T cell activation and, in humans, it can no longer be used as an exclusive marker of nTregs. These data indicate that our current understanding of how FOXP3 contributes to immune tolerance in humans needs to be re-evaluated.

Keywords: human, T cells, T cell activation, tolerance, transcription factors

Received 11 December 2006, accepted 24 January 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Exp. Med.Home page
J. Andersson, D. Q. Tran, M. Pesu, T. S. Davidson, H. Ramsey, J. J. O'Shea, and E. M. Shevach
CD4+FoxP3+ regulatory T cells confer infectious tolerance in a TGF-{beta}-dependent manner
J. Exp. Med., September 1, 2008; 205(9): 1975 - 1981.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. N. Golovina, T. Mikheeva, M. M. Suhoski, N. A. Aqui, V. C. Tai, X. Shan, R. Liu, R. R. Balcarcel, N. Fisher, B. L. Levine, et al.
CD28 Costimulation Is Essential for Human T Regulatory Expansion and Function
J. Immunol., August 15, 2008; 181(4): 2855 - 2868.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Kavanagh, S. O'Brien, D. Lee, Y. Hou, V. Weinberg, B. Rini, J. P. Allison, E. J. Small, and L. Fong
CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion
Blood, August 15, 2008; 112(4): 1175 - 1183.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Zheng, C. N. Manzotti, F. Burke, L. Dussably, O. Qureshi, L. S. K. Walker, and D. M. Sansom
Acquisition of Suppressive Function by Activated Human CD4+CD25- T Cells Is Associated with the Expression of CTLA-4 Not FoxP3
J. Immunol., August 1, 2008; 181(3): 1683 - 1691.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. Nagar, H. Vernitsky, Y. Cohen, D. Dominissini, Y. Berkun, G. Rechavi, N. Amariglio, and I. Goldstein
Epigenetic inheritance of DNA methylation limits activation-induced expression of FOXP3 in conventional human CD25-CD4+ T cells
Int. Immunol., August 1, 2008; 20(8): 1041 - 1055.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. I. Zonios, J. Falloon, J. E. Bennett, P. A. Shaw, D. Chaitt, M. W. Baseler, J. W. Adelsberger, J. A. Metcalf, M. A. Polis, S. J. Kovacs, et al.
Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors
Blood, July 15, 2008; 112(2): 287 - 294.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
B Zhang, X Zhang, F L Tang, L P Zhu, Y Liu, and P E Lipsky
Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus
Ann Rheum Dis, July 1, 2008; 67(7): 1037 - 1040.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. Ebinuma, N. Nakamoto, Y. Li, D. A. Price, E. Gostick, B. L. Levine, J. Tobias, W. W. Kwok, and K.-M. Chang
Identification and In Vitro Expansion of Functional Antigen-Specific CD25+ FoxP3+ Regulatory T Cells in Hepatitis C Virus Infection
J. Virol., May 15, 2008; 82(10): 5043 - 5053.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Mahic, S. Yaqub, T. Bryn, K. Henjum, D. M. Eide, K. M. Torgersen, E. M. Aandahl, and K. Tasken
Differentiation of naive CD4+ T cells into CD4+CD25+FOXP3+ regulatory T cells by continuous antigen stimulation
J. Leukoc. Biol., May 1, 2008; 83(5): 1111 - 1117.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M Bonelli, K von Dalwigk, A Savitskaya, J S Smolen, and C Scheinecker
Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis
Ann Rheum Dis, May 1, 2008; 67(5): 664 - 671.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. M. Ebert, B. S. Tan, J. Browning, S. Svobodova, S. E. Russell, N. Kirkpatrick, C. Gedye, D. Moss, S. P. Ng, D. MacGregor, et al.
The Regulatory T Cell-Associated Transcription Factor FoxP3 Is Expressed by Tumor Cells
Cancer Res., April 15, 2008; 68(8): 3001 - 3009.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Rynda, M. Maddaloni, D. Mierzejewska, J. Ochoa-Reparaz, T. Maslanka, K. Crist, C. Riccardi, B. Barszczewska, K. Fujihashi, J. R. McGhee, et al.
Low-Dose Tolerance Is Mediated by the Microfold Cell Ligand, Reovirus Protein {sigma}1
J. Immunol., April 15, 2008; 180(8): 5187 - 5200.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Tuovinen, E. Kekalainen, L. H. Rossi, J. Puntila, and T. Petteri Arstila
Cutting Edge: Human CD4-CD8- Thymocytes Express FOXP3 in the Absence of a TCR
J. Immunol., March 15, 2008; 180(6): 3651 - 3654.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
L. Passerini, S. E. Allan, M. Battaglia, S. Di Nunzio, A. N. Alstad, M. K. Levings, M. G. Roncarolo, and R. Bacchetta
STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells
Int. Immunol., March 1, 2008; 20(3): 421 - 431.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Li, E. J. Gowans, C. Chougnet, M. Plebanski, and U. Dittmer
Natural Regulatory T Cells and Persistent Viral Infection
J. Virol., January 1, 2008; 82(1): 21 - 30.
[Full Text] [PDF]


Home page
BloodHome page
V. Pillai and N. J. Karandikar
Attack on the clones? Human FOXP3 detection by PCH101, 236A/E7, 206D, and 259D reveals 259D as the outlier with lower sensitivity
Blood, January 1, 2008; 111(1): 463 - 464.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Vence, A. K. Palucka, J. W. Fay, T. Ito, Y.-J. Liu, J. Banchereau, and H. Ueno
Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma
PNAS, December 26, 2007; 104(52): 20884 - 20889.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. Karlsson, B. Malleret, P. Brochard, B. Delache, J. Calvo, R. Le Grand, and B. Vaslin
FoxP3+ CD25+ CD8+ T-Cell Induction during Primary Simian Immunodeficiency Virus Infection in Cynomolgus Macaques Correlates with Low CD4+ T-Cell Activation and High Viral Load
J. Virol., December 15, 2007; 81(24): 13444 - 13455.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. A. Hombach, D. Kofler, A. Hombach, G. Rappl, and H. Abken
Effective Proliferation of Human Regulatory T Cells Requires a Strong Costimulatory CD28 Signal That Cannot Be Substituted by IL-2
J. Immunol., December 1, 2007; 179(11): 7924 - 7931.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. G. Evans, T. Suddason, I. Jackson, L. S. Taams, and G. M. Lord
Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes
PNAS, October 23, 2007; 104(43): 17034 - 17039.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Q. Tran, H. Ramsey, and E. M. Shevach
Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-{beta} dependent but does not confer a regulatory phenotype
Blood, October 15, 2007; 110(8): 2983 - 2990.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
J. E. Lopes, D. M. Soper, and S. F. Ziegler
Foxp3 Is Required Throughout the Life of a Regulatory T Cell
Sci. Signal., July 3, 2007; 2007(393): pe36 - pe36.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.